title: B-cell targeted therapy alone may not be effective in bullous pemphigoid.
authors.forename: R
authors.initials: R
authors.lastname: Chee
authors.forename: V
authors.initials: V
authors.lastname: Nagendran
authors.forename: A
authors.initials: A
authors.lastname: Bansal
authors.forename: S N
authors.initials: SN
authors.lastname: Casie Chetty
authors.forename: C
authors.initials: C
authors.lastname: Harland
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000187:drug effects*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008212:Lymphocyte Depletion; D008297:Male; D010391:Pemphigoid, Bullous / Q000188:drug therapy*; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab